STN-tTIS Modulates Parkinson Motor Symptoms With and Without Medications
Not Applicable
- Conditions
- Parkinson Disease
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06980935
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2
Recruiting
- Conditions
- AMLMDS
- Interventions
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 126
- Registration Number
- NCT06972641
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
The Efficacy and Safety of Puerarin in Obesity Treatment
Phase 2
Not yet recruiting
- Conditions
- Metabolic DiseasesObesity/Therapy
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT06968208
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Adjuvant Pancreatic Therapy Guided by MRD
Not Applicable
Not yet recruiting
- Conditions
- Pancreatic Adenocarcinoma Resectable
- Interventions
- Diagnostic Test: circulating tumor DNA (ctDNA)-based MRDDrug: adjuvant chemotherapy regimens
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 856
- Registration Number
- NCT06966440
- Locations
- 🇨🇳
Ruijing Hospital, Shanghai, China
A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma
Not yet recruiting
- Conditions
- Peripheral T-cell Lymphoma (PTCL)
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06963632
A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center
Active, not recruiting
- Conditions
- Pemphigus DiseaseRituximab (RTx)Intravenous Immunoglobulin
- First Posted Date
- 2025-04-29
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT06949241
- Locations
- 🇨🇳
Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Early Phase 1
Not yet recruiting
- Conditions
- Acute Graft-versus-Host Disease
- Interventions
- Combination Product: conventional aGVHD prophylaxisBiological: iMSC
- First Posted Date
- 2025-04-29
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 56
- Registration Number
- NCT06949267
Airway Basal Stem Cell Therapy in Chronic Obstructive Pulmonary Disease (COPD)
Phase 1
Not yet recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Biological: P63+ lung progenitors
- First Posted Date
- 2025-04-27
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06946953
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia
Phase 1
Not yet recruiting
- Conditions
- Dementia
- Interventions
- Drug: Peptide PMS-001 Intravenous InjectionDrug: Placebo
- First Posted Date
- 2025-04-27
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06946511
- Locations
- 🇨🇳
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery
Not Applicable
Not yet recruiting
- Conditions
- Rectal CancerSurgery
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 212
- Registration Number
- NCT06943690
- Locations
- 🇨🇳
The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, Henan, China
🇨🇳Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
🇨🇳Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath